Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5334777 | 0.91 | FDPS (0.38) | DNM1FDPSALDH1A1 | |
| SCHEMBL987703 | 0.91 | FDPS (0.38) | DNM1FDPSALDH1A1 | |
| SCHEMBL14484193 | 0.91 | FDPS (0.38) | DNM1FDPSALDH1A1 | |
| SCHEMBL28418766 | 0.75 | LMNA (0.42) | DNM1FDPSALDH1A1 | |
| SCHEMBL3725398 | 0.75 | LMNA (0.42) | DNM1FDPSALDH1A1 | |
| SCHEMBL1903588 | 0.75 | LMNA (0.42) | DNM1FDPSALDH1A1 | |
| SCHEMBL30803745 | 0.75 | LMNA (0.42) | DNM1FDPSALDH1A1 | |
| SCHEMBL28675045 | 0.75 | LMNA (0.42) | DNM1FDPSALDH1A1 | |
| SCHEMBL7895556 | 0.75 | LMNA (0.42) | DNM1FDPSALDH1A1 | |
| SCHEMBL28938048 | 0.74 | DNM1 (0.39) | DNM1FDPSALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109563186-B | Method for producing modified conjugated diene polymer and method for producing polymer composition | 住友化学株式会社 | 2022-04-15 | — | — | CN | disclosed |
| US-20040082803-A1 | Trichlorosilyl groups containing organochlorosilanes and their preparation methods by the double-silylation of olefins with trichlorosilane | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082803-A1 | Trichlorosilyl groups containing organochlorosilanes and their preparation methods by the double-silylation of olefins with trichlorosilane | CBR1, OXSR1, HCCS | DNM1 3474/4885FDPS 3128/4885ALDH1A1 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.